LACEY KELLER: Open Payments
NPI 1548713290 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$581 in 5 payments from 5 companies in 2025. Trend: 2023 $426 · 2024 $244 · 2025 $581
Food & beverage: $581
| Company | Payments | Amount |
|---|---|---|
| Organogenesis Inc. | 1 | $181 |
| Boston Scientific Corporation | 1 | $135 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| Novo Nordisk Inc | 1 | $124 |
| Novartis Pharmaceuticals Corporation | 1 | $16 |
Products named: PURAPLY WOUND MATRIX, WATCHMAN FLX, Auvelity, Ozempic, LEQVIO.
Industry payments across IN — which companies pay providers there.
